Baxter Thrives on Injectable Medicine – Moneynews (blog)

Its biosciences unit accounts for about 44 percent of sales. Its products include recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders and plasma-based therapies to treat immune deficiencies and other conditions. Bing News – Full Story →

Share
This entry was posted in Bleeding Disorders and tagged , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>